Journal List > Allergy Asthma Respir Dis > v.2(4) > 1059048

Jeon, Nam, Kim, Choi, Kim, Lee, Nam, Song, and Lee: Serotonin syndrome associated with linezolid

Abstract

Serotonin syndrome (SS) is a potentially life-threatening drug reaction characterized by mental status change, increased neuromuscular tone, and autonomic instability. Linezolid, an oxazolidinone antibacterial agent, is widely used in general hospitals; however, it interacts with some serotonin agonists and may cause SS. We report a case of SS caused by linezolid, without the concomitant use of serotonin agonist. A 72-year-old patient was admitted due to recurrent wound infection of his left ankle. He developed fever, skin rash, and renal function deterioration, and blood eosinophils and liver enzymes increased after administration of vancomycin. The antibiotic was changed to linezolid against methicillin-resistant Staphylococcus aureus. Four days later, he developed agitation, fever, increased blood pressure, and tachycardia. There were no abnormal findings in laboratory and image tests, including brain and chest computed tomography suggesting the cause of his symptoms. He had not taken any serotonin agonists, including serotonin uptake inhibitors and monoamineoxidase-inhibiting antidepressants. When administration of linezolid was stopped, his symptoms improved within 24 hours and fully recovered within 2 days without additional treatments.

Figures and Tables

Fig. 1
Chest computed tomography shows pleural effusion.
aard-2-310-g001
Fig. 2
Brain magnetic resonance imaging shows atropic changes.
aard-2-310-g002
Fig. 3
The change of clinical parameters including systolic blood pressure (aard-2-310-i001), body temperature (aard-2-310-i002), heart rate (aard-2-310-i003), and serum eosinophil count (aard-2-310-i004) during admission.
aard-2-310-g003

Notes

This research was supported by a grant from Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center in 2014.

References

1. Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P, et al. The serotonin 5-HT7 receptors: two decades of research. Exp Brain Res. 2013; 230:555–568.
crossref
2. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003; 168:1439–1442.
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 352:1112–1120.
crossref
4. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003; 138:135–142.
crossref
5. Wigen CL, Goetz MB. Serotonin syndrome and linezolid. Clin Infect Dis. 2002; 34:1651–1652.
crossref
6. Quinn DK, Stern TA. Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry. 2009; 11:353–356.
crossref
7. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003; 36:159–168.
crossref
8. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003; 124:1789–1797.
9. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006; 42:1578–1583.
crossref
10. Alisky JM. Can chlorpheniramine cause serotonin syndrome? Singapore Med J. 2006; 47:1014.
11. Savard S, Desmeules S, Riopel J, Agharazii M. Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis. 2009; 54:e17–e20.
crossref
12. Mills KC. Serotonin syndrome. Am Fam Physician. 1995; 52:1475–1482.
13. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991; 148:705–713.
crossref
TOOLS
Similar articles